Lessee, Operating Lease, Liability, to be Paid in USD of Apellis Pharmaceuticals, Inc. from Q1 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Apellis Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and change rate from Q1 2019 to Q4 2024.
  • Apellis Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending 31 Dec 2024 was $18.3M, a 7.49% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

Apellis Pharmaceuticals, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $18.3M -$1.48M -7.49% 31 Dec 2024 10-K 28 Feb 2025
Q3 2024 $19.7M +$1.18M +6.36% 30 Sep 2024 10-Q 05 Nov 2024
Q2 2024 $19M -$1.12M -5.57% 30 Jun 2024 10-Q 01 Aug 2024
Q1 2024 $17.7M -$3.86M -17.9% 31 Mar 2024 10-Q 07 May 2024
Q4 2023 $19.8M -$2.98M -13.1% 31 Dec 2023 10-K/A 29 Feb 2024
Q3 2023 $18.5M -$5.32M -22.3% 30 Sep 2023 10-Q 01 Nov 2023
Q2 2023 $20.1M -$5.38M -21.1% 30 Jun 2023 10-Q 31 Jul 2023
Q1 2023 $21.5M -$3.5M -14% 31 Mar 2023 10-Q 04 May 2023
Q4 2022 $22.8M -$2.54M -10.1% 31 Dec 2022 10-K 21 Feb 2023
Q3 2022 $23.8M -$2.9M -10.8% 30 Sep 2022 10-Q 07 Nov 2022
Q2 2022 $25.5M -$2.73M -9.67% 30 Jun 2022 10-Q 08 Aug 2022
Q1 2022 $25M -$4.14M -14.2% 31 Mar 2022 10-Q 04 May 2022
Q4 2021 $25.3M +$2.82M +12.5% 31 Dec 2021 10-K 28 Feb 2022
Q3 2021 $26.7M +$3.65M +15.8% 30 Sep 2021 10-Q 08 Nov 2021
Q2 2021 $28.2M +$12.1M +75.5% 30 Jun 2021 10-Q 09 Aug 2021
Q1 2021 $29.2M +$12.1M +70.8% 31 Mar 2021 10-Q 28 Apr 2021
Q4 2020 $22.5M +$4.81M +27.2% 31 Dec 2020 10-K 25 Feb 2021
Q3 2020 $23.1M +$6.33M +37.8% 30 Sep 2020 10-Q 02 Nov 2020
Q2 2020 $16.1M +$7.74M +92.8% 30 Jun 2020 10-Q 30 Jul 2020
Q1 2020 $17.1M +$8.73M +105% 31 Mar 2020 10-Q 29 Apr 2020
Q4 2019 $17.7M 31 Dec 2019 10-K 27 Feb 2020
Q3 2019 $16.8M 30 Sep 2019 10-Q 05 Nov 2019
Q2 2019 $8.33M 30 Jun 2019 10-Q 31 Jul 2019
Q1 2019 $8.35M 31 Mar 2019 10-Q 07 May 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.